1. Home
  2. PGEN vs SGRY Comparison

PGEN vs SGRY Comparison

Compare PGEN & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.21

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo Surgery Partners Inc.

SGRY

Surgery Partners Inc.

N/A

Current Price

$26.80

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PGEN
SGRY
Founded
1998
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
PGEN
SGRY
Price
$4.21
$26.80
Analyst Decision
Buy
Hold
Analyst Count
4
7
Target Price
$13.67
★ $24.40
AVG Volume (30 Days)
6.8M
★ 6.9M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.14
EPS
★ 0.12
N/A
Revenue
$230,981,000.00
★ $1,145,438,000.00
Revenue This Year
$2,380.31
N/A
Revenue Next Year
$84.01
N/A
P/E Ratio
$34.63
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.04
$11.41
52 Week High
$8.98
$27.23

Technical Indicators

Market Signals
Indicator
PGEN
SGRY
Relative Strength Index (RSI) 31.74 84.80
Support Level $3.89 $13.26
Resistance Level $4.41 $27.23
Average True Range (ATR) 0.36 0.35
MACD -0.01 -0.11
Stochastic Oscillator 16.78 89.89

Price Performance

Historical Comparison
PGEN
SGRY

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About SGRY Surgery Partners Inc.

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.

Share on Social Networks: